Log In
Print
BCIQ
Print
Print this Print this
 

MK-3222 (formerly SCH 900222)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionAnti-IL-23 antibody
Molecular Target Interleukin-23 (IL-23)
Mechanism of ActionAntibody
Latest Stage of DevelopmentPhase III
IndicationPsoriasis
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today